However, the inverse association between loss of SOX9 overexpression and PTEN deletion found in ERG-positive cancers indicates that very high SOX9 protein levels—as induced by ERG-fusion—might not per se provide a selection advantage to PTEN-deleted cancer cells. The gene discussed is ERG; the disease is cancer.